Following a boom in large, transformative medtech mega-mergers over the past few years, the landscape for medical device deals calmed down in 2017. Though the total number of deals in 2017 to date remains stagnant, totaling approximately 2,700 deals each year for the past four years, this year has seen a slight rise in capital raisings as the number of mergers and acquisitions continues to decline.
Despite this small uptick in capital raisings, which include equity and debt offerings, private equity, and venture financing, medtech continues to struggle with investment and venture capital compared to many other industries. Large medical device companies and investors alike are increasingly holding out for a secure return on investment before acquiring or financing smaller medical device companies and startups.
